Pharmapack Europe 2014: A New Impulse Towards Internationalization

Jan 8, 2014

The 13th edition of Pharmapack Europe will be held on 12 and 13 February 2014, at Paris Expo, Porte de Versailles. More than 3,000 visitors and 320 exhibitors from over 70 countries will gather in this new venue to take stock of the latest innovations in packaging and delivery systems for drugs and healthcare products. ...

Read More

Strategies for Successful Analytical Technology Transfer

Jan 8, 2014

Technology Transfer is an expression that most people in the pharmaceutical industry are familiar with or have some experience of.  However, ask someone to explain what it is in simple terms and you will probably receive a variety of answers.  Paul Smith at Agilent Technologies explains the need to define a formal TT process arises because of the regulatory, business and ultimately patient risks that an unsuccessful transfer may represent. ...

Read More

Smart Synthesis, Membrane Filtration and Chromatography

Jan 8, 2014

For Time-efficient and Cost-effective Production, at the Required Purity Molecules reaching the market in recent years present an ever-growing complexity. In the meantime, purity criteria are more important than ever to ensure patient safety. Aline Devoille at Novasep looks into how the combination of these two facts represents a big challenge for the manufacturing industry, where the right combination of state-of-the-art synthesis and advanced purification is necessary to meet the demand in a cost-effective and time-efficient manner. (Due to an error in printing, this article is a re-run from the previous issue of IPI. – Volume 5 Issue 2) ...

Read More

The Impact of the GDP Guidelines on Design, Qualification and Validation of Packaging Systems

Jan 8, 2014

Drugs can be damaged by adverse external exposures and thus lose efficacy or become toxic, even deadly. A key area that affects drugs is temperature exposure. Temperature-related damage to drugs is not readily visible and can occur at any point in the supply chain.  David Walsh of Intelsius reviews the new European Union (EU) Guidelines for Good Distribution Practices (GDP) and explains why they are designed so that a product not just makes it to the doctor’s office or pharmacy but is maintained at the appropriate temperature throughout its journey to ensure its safety and efficacy when it reaches the ...

Read More